Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Serum Levels of Trace Elements in Patients with Prostate Cancer

  • Kaba, Mehmet (Department of Urology, Faculty of Medicine, Yuzuncu Yil University) ;
  • Pirincci, Necip (Department of Urology, Faculty of Medicine, Yuzuncu Yil University) ;
  • Yuksel, Mehmet Bilgehan (Department of Urology, Faculty of Medicine, Celal Bayar University) ;
  • Gecit, Ilhan (Department of Urology, Faculty of Medicine, Yuzuncu Yil University) ;
  • Gunes, Mustafa (Department of Urology, Faculty of Medicine, Yuzuncu Yil University) ;
  • Ozveren, Huseyin (Department of Urology, Faculty of Medicine, Yuzuncu Yil University) ;
  • Eren, Huseyin (Department of Urology, Faculty of Medicine, Yuzuncu Yil University) ;
  • Demir, Halit (Department of Chemistry, Faculty of Science and Art, Yuzuncu Yil University)
  • Published : 2014.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Trace elements are major components of biological structures; however, excessive levels of these elements can be toxic. Materials and Methods: In the present study, serum levels of trace elements were measured in 30 patients with newly diagnosed as prostate cancer and 32 healthy volunteer by using furnace atomic absorption spectrophotometry. Results: It was found that there was an increase in serum levels of Co, Cu, Mg and Pb (p<0.05), whereas a decrease in serum levels of Fe, Mn, and Zn levels in patients with prostate cancer (p<0.05). Conclusions: These changes may be important in the pathogenesis of prostate cancers; however, further prospective studies are needed to identify relationships between prostate cancer and trace elements.

Keywords

References

  1. Achanzar WE, Diwan BA, Liu J, et al (2001). Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res, 61, 455-8.
  2. Andrews NC (2008). Forging a field: the golden age of iron biology. Blood, 112, 219-30. https://doi.org/10.1182/blood-2007-12-077388
  3. Arredondo M, Nunez MT (2005). Iron and copper metabolism. Mol Aspects Med, 26, 313-27. https://doi.org/10.1016/j.mam.2005.07.010
  4. Arslan M, Demir H, Arslan H, Gokalp AS, Demir C (2011). Trace elements, heavy metals and other biochemical parameters in malignant glioma patients. Asian Pac J Cancer Prev, 12, 447-51.
  5. Banas A, Kwiatek WM, Banas K, et al (2010). Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem, 15, 1147-55. https://doi.org/10.1007/s00775-010-0675-5
  6. Brys M, Nawrocka AD, Miekos E, et al (1997). Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res, 59, 145-52. https://doi.org/10.1007/BF02783239
  7. Collery P, Anghileri LJ, Coudoux P, et al (1981). Magnesium and cancer: clinical data. Magnesium Bull, 3, 11-20.
  8. Costello LC, Franklin RB (1998). Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate, 35, 285-96. https://doi.org/10.1002/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F
  9. Costello LC, Franklin RB, Narayan P (1999). Citrate in the diagnosis of prostate cancer. Prostate, 38, 237-45. https://doi.org/10.1002/(SICI)1097-0045(19990215)38:3<237::AID-PROS8>3.0.CO;2-O
  10. Costello LC, Liu Y, Zou J, Franklin RB (1999). Evidence for a zinc uptake transporter in human prostate cancer cell which is regulated by prolaction and testosterone. J Biol Chem. 274, 17499-504. https://doi.org/10.1074/jbc.274.25.17499
  11. Cunzhi H, Jiexian J, Xianwen Z, et al (2003). Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res, 94, 113-22. https://doi.org/10.1385/BTER:94:2:113
  12. Eisenstein RS (2000). Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr, 20, 627-62. https://doi.org/10.1146/annurev.nutr.20.1.627
  13. El-Serag HB, Mason AC (2000). Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med, 160, 3227-30. https://doi.org/10.1001/archinte.160.21.3227
  14. Ganz T, Nemeth E (2006). Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol, 290, 199-203. https://doi.org/10.1152/ajpgi.00412.2005
  15. Gecit I, Kavak S, Meral I, et al (2011). Effects of shock waves on oxidative stress, antioxidant enzyme and element levels in kidney of rats. Biol Trace Elem Res, 144, 1069-76. https://doi.org/10.1007/s12011-011-9124-8
  16. Gecit I, Kavak S, Demir H, et al (2011). Serum trace element levels in patients with bladder cancer. Asian Pac J Cancer Prev, 12, 3409-13.
  17. George DJ, Halabi S, Shepard TF, et al (2005). The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480. Clin Cancer Res, 11, 1815-20. https://doi.org/10.1158/1078-0432.CCR-04-1560
  18. Geraki K, Farquharson MJ, Bradley DA (2002). Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys Med Biol , 47, 2327-39. https://doi.org/10.1088/0031-9155/47/13/310
  19. Geraki K, Farquharson MJ, Bradley DA (2004). X-ray fluorescence and energy dispersive x-ray diffraction for the quantification of elemental concentrations in breast tissue. Phys Med Biol, 49, 99-110. https://doi.org/10.1088/0031-9155/49/1/007
  20. Geraki K, Farquharson MJ, Bradley DA, Hugtenburg RP (2004). Nucl Instrum Methods Phys Res B, 213, 564-8. https://doi.org/10.1016/S0168-583X(03)01672-0
  21. Goyer RA, Liu J, Waalkes MP (2004). Cadmium and cancer of prostate and testis. Biometals, 17, 555-8. https://doi.org/10.1023/B:BIOM.0000045738.59708.20
  22. Gronberg, H (2003). Prostate cancer epidemiology. Lancet, 361, 859-64. https://doi.org/10.1016/S0140-6736(03)12713-4
  23. Guntupalli JN, Padala S, Gummuluri AV, et al (2008). Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particleinduced X-ray emission technique. Eur J Cancer Prev, 16, 108-15.
  24. Gyorkey F, Min KW, Huff JA, Gyorkey P (1967). Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res, 27, 1348-53.
  25. Harris GK, Shi X (2003). Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutat Res, 533, 183-200. https://doi.org/10.1016/j.mrfmmm.2003.08.025
  26. Hartwig A (2010). Mechanisms in cadmium-induced carcinogenicity: recent insights. Biometals, 23, 951-60 https://doi.org/10.1007/s10534-010-9330-4
  27. Inskip PD, Linet MS, Heineman EF (1995). Etiology of brain tumors in adults. Epidemiol Rev, 17, 382-414.
  28. Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics. CA Cancer J Clin, 57, 43-66. https://doi.org/10.3322/canjclin.57.1.43
  29. Jarup L (2003). Hazards of heavy metal contamination. Br Med Bull, 68, 167-82. https://doi.org/10.1093/bmb/ldg032
  30. Karimi G, Shahar S, Homayouni N, et al (2012). Association between trace element and heavy metal levels in hair and nail with prostate cancer. Asian Pac J Cancer Prev, 13, 4249-53. https://doi.org/10.7314/APJCP.2012.13.9.4249
  31. Killilea AN, Downing KH, Killilea DW.(2007). Zinc deficiency reduces paclitaxel efficacy in LNCaP prostate cancer cells. Cancer Lett, 258, 70-9. https://doi.org/10.1016/j.canlet.2007.08.010
  32. Knekt P, Reunanen A, Takkunen H et al (1994). Body iron stores and risk of cancer. Int J Cancer, 56, 379-82. https://doi.org/10.1002/ijc.2910560315
  33. Kuvibidila S, Gauthier T, Warrier RR, Rayford W (2004). Increased levels of serum ferritin receptor and serum transferring receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med, 144, 176-82. https://doi.org/10.1016/j.lab.2004.03.017
  34. Lindegaard PM, Hansen SO, Christensen JE, Andersen BB, Andersen O (1990). The distribution of cadmium within the human prostate. Biol Trace Elem Res, 25, 97-104. https://doi.org/10.1007/BF02990270
  35. Mahata J, Basu A, Ghoshal S, et al (2003). Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res, 534, 133-43. https://doi.org/10.1016/S1383-5718(02)00255-3
  36. Mainous AG, Wells BJ, Koopman RJ, Everett CJ, Gill JM (2005). Iron, lipids, and risk of cancer in the framingham offspring cohort. Am J Epidemiol, 161, 1115-22. https://doi.org/10.1093/aje/kwi131
  37. Majumder S, Chatterjee S, Pal S, et al (2009). The role of copper in drug-resistant murine and human tumors. Biometals, 22, 377-84. https://doi.org/10.1007/s10534-008-9174-3
  38. Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer, 90, 2312-6.
  39. Mori H, Morishita Y, Mori Y, et al (1992). Effect of magnesium hydroxide on methylazoxymethanol acetate- induced epithelial proliferation in the largebowels of rats. Cancer Lett, 62,43-8. https://doi.org/10.1016/0304-3835(92)90196-3
  40. Naga Raju GJ, Sarita P, Ramana Murty GA, et al (2006). Estimation of trace elements in some anti-diabetic medicinal plants using PIXE technique. Appl Radiat Isot, 64, 893-900. https://doi.org/10.1016/j.apradiso.2006.02.085
  41. Nakamura K, Yasunaga Y, Ko D, et al (2002). Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int J Oncol, 20, 543-47.
  42. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA (2002). An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens, 16, 123-31. https://doi.org/10.1038/sj.jhh.1001300
  43. Piccinini L, Borella P, Bargellini A, Medici CI, Zoboli A (1996). A case- control study on selenium, zinc, and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Element Res, 51, 23-30. https://doi.org/10.1007/BF02790144
  44. Pirincci N, Gecit I, Gunes M, et al (2013). Levels of serum trace elements in renal cell carcinoma cases. Asian Pac J Cancer Prev, 14, 499-502. https://doi.org/10.7314/APJCP.2013.14.1.499
  45. Reddy MB, Clark L (2004). Iron, oxidative stress, and disease risk. Nutr Rev, 62, 120-4. https://doi.org/10.1111/j.1753-4887.2004.tb00033.x
  46. Sayir F, Kavak S, Meral I, Demir H, Cengiz N, Cobanoglu U (2013). Effects of crush and axotomy on oxidative stress and some trace element levels in phrenic nerve of rats. Brain Res Bull, 92, 84-8. https://doi.org/10.1016/j.brainresbull.2011.07.013
  47. Theophanides T, Anastassopoulou J (2002). Copper and carcinogenesis. Crit Rev Oncol Hematol, 42, 57-64. https://doi.org/10.1016/S1040-8428(02)00007-0
  48. Tokar EJ, Diwan BA, Waalkes MP (2010). Early life inorganic lead exposure induces testicular teratoma and renal and urinary bladder preneoplasia in adult metallothioneinknockout mice but not in wild type mice. Toxicology, 276, 5-10. https://doi.org/10.1016/j.tox.2010.06.006
  49. Turecky L, Kalina P, Uhlikova E, Namerova S, Krizko J (1984). Serum ceruloplasmin and copper levels in patients with primary brain tumors. Klin Wochenschr, 62, 187-9. https://doi.org/10.1007/BF01731643
  50. Uauy R, Olivares M, Gonzalez M (1998). Essentiality of copper in humans. Am J Clin Nutr, 67, 952-9.
  51. Vinceti M, Venturelli M, Sighinolfi C, et al (2007). Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ, 373, 77-8. https://doi.org/10.1016/j.scitotenv.2006.11.005
  52. Waalkes MP (2003). Cadmium carcinogenesis. Mutat Res, 533, 107-20. https://doi.org/10.1016/j.mrfmmm.2003.07.011
  53. Waisberg M, Joseph P, Hale B, Beyersmann D (2003). Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology, 192, 95-117. https://doi.org/10.1016/S0300-483X(03)00305-6
  54. Wijngaarden EV, Dosemeci M (2006). Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int J Cancer, 119, 1136-44. https://doi.org/10.1002/ijc.21947
  55. Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E (2004). Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol, 14, 195-201. https://doi.org/10.1016/S1047-2797(03)00119-4
  56. Yaman M, Atici D, Bakirdere S, Akdeniz I. (2005). Comparison of trace metal concentrations in malign and benign human prostate. J Med Chem, 48, 630-4. https://doi.org/10.1021/jm0494568
  57. Yaman M, Kaya G, Simsek M (2007). Comparision of trace elements concentrations in cancerous and noncancerous human endometrial and ovary tissues. Int J Gynecol Cancer, 17, 220-8. https://doi.org/10.1111/j.1525-1438.2006.00742.x
  58. Zacharski LR, Chow BK, Howes PS, et al (2008). Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial. J Natl Cancer Inst, 100, 996-1002. https://doi.org/10.1093/jnci/djn209
  59. Zowczak M, Iskra M, Torlinski L, Cofta S (2001). Analysis of serum copper and zinc concentration in cancer patients. Biol Trace Elem Res, 82, 1-8. https://doi.org/10.1385/BTER:82:1-3:001

Cited by

  1. Prostate-Specific Antigen Levels in Relation to Background Factors: Are there Links to Endocrine Disrupting Chemicals and AhR Expression? vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6121
  2. Serum Copper and Zinc Levels Among Iranian Colorectal Cancer Patients vol.170, pp.2, 2016, https://doi.org/10.1007/s12011-015-0483-4
  3. The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancer pp.07302312, 2018, https://doi.org/10.1002/jcb.27617
  4. Copper and zinc in stage I multiple myeloma: relation with ceruloplasmin, lipid peroxidation, and superoxide dismutase activity vol.0, pp.0, 2018, https://doi.org/10.1515/hmbci-2018-0055